Evaluating the Safety and Immune Response of a Prime-Boost HIV Vaccine Regimen in Healthy, HIV-Uninfected, Vaccinia-Naive Adults
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Christine (Mhorag) Hay
University of Rochester
Study Chair - Susan Buchbinder
San Francisco Department of Public Health
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Alabama Crs
Birmingham, Alabama, United States
- Bridge Hiv Crs
San Francisco, California, United States
- Brigham and Women'S Hospital Vaccine Crs (bwh Vcrs)
Boston, Massachusetts, United States
- University of Rochester Vaccines To Prevent Hiv Infection Crs
Rochester, New York, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2012
- Primary completion
- 31 Aug 2014
- Completion
- 31 Jan 2016
- Last update posted
- 15 Oct 2021
- Registered enrollment
- 48
- Registry id
- NCT01571960
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.